- Home
- REXR vs KYMR Comparison
REXR vs KYMR Comparison
Compare REXR & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REXR | KYMR |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | United States |
| Employees | 256 | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 6.8B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | REXR | KYMR |
|---|---|---|
| Price | $36.04 | $86.83 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 26 |
| Target Price | $41.00 | ★ $107.72 |
| AVG Volume (30 Days) | ★ 2.3M | 486.1K |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.91% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,211,000.00 |
| Revenue This Year | $0.09 | $10.61 |
| Revenue Next Year | $2.99 | $8.17 |
| P/E Ratio | $43.28 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $32.14 | $28.06 |
| 52 Week High | $44.38 | $103.00 |
Technical Indicators
Market Signals| Indicator | REXR | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 53.16 |
| Support Level | $35.66 | $77.78 |
| Resistance Level | $37.77 | $90.15 |
| Average True Range (ATR) | 0.93 | 3.19 |
| MACD | 0.21 | -0.22 |
| Stochastic Oscillator | 61.26 | 44.70 |
Price Performance
Historical ComparisonAbout REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust focused on owning, operating and acquiring industrial properties in Southern California infill markets. Its goal is to generate attractive risk-adjusted returns for the stockholders by providing superior access to industrial property investments and mortgage debt investments secured by industrial property in high-barrier Southern California infill markets. The company generates revenue from rental income derived from properties in its portfolio.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.